Preclinical and Nonclinical Testing

Plan your next preclinical study today or partner with us for an IND- / CTA-enabling package to get you from bench to post-market faster. Choose from thousands of non-GLP and GLP studies with a variety of administration routes, techniques and disease models. In addition to pharmaceutical preclinical testing, we also offer nonclinical testing for crop protection, chemicals and medical devices. Find out more about what #CovanceDoes


IND Enabling & Early Phase Solutions

  • Lead optimization through IND/CTA enabling 

  • IND/CTA through first-in-human


Thinking about selling or licensing your compund? Consider joining Marketplace, a secure online portal to share asset information with companies looking to expand a pipeline. 

Global Preclinical CRO Staff and Testing Facilities

  • More than 4,000 nonclinical testing staff around the world

  • Over 5 million gross square footage of preclinical facilities and labs

Screenshot (3819)

Oncology Webinar Series

The oncology webinar series kicks off with a view of trends in immunotherapies including preclinical model selection, biomarkers of safety and efficacy, and specific trial design and medical monitoring considerations. 

DDI & Modeling Webinar

Download or watch the recording of this webinar that explores PBPK modeling to support clinical DDI studies. 

Choose from a variety of IND-enabling or CTA-enabling packages to save on switching costs and reduce time gaps between studies. More on programmatic solutions >

Check out MarketPlace, our unique platform that helps you put your compound in front of companies seeking to expand their portfolio for clinical trials and beyond. 

Nonclinical Therapeutic & Specialty Areas